Jonathan Burth - Nov 1, 2023 Form 4 Insider Report for Vita Coco Company, Inc. (COCO)

Role
Chief Operating Officer
Signature
By: Yolanda Goettsch, Attorney-in-Fact For: Jonathan Burth
Stock symbol
COCO
Transactions as of
Nov 1, 2023
Transactions value $
-$886,599
Form type
4
Date filed
11/3/2023, 06:21 PM
Previous filing
Sep 18, 2023
Next filing
Nov 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COCO Common Stock Sale -$294K -10.5K -5.26% $28.05 189K Nov 1, 2023 Direct F1, F2, F3
transaction COCO Common Stock Sale -$363K -12.1K -6.4% $30.04 177K Nov 2, 2023 Direct F1, F4
transaction COCO Common Stock Options Exercise $118K +11.6K +6.57% $10.18 188K Nov 2, 2023 Direct
transaction COCO Common Stock Sale -$348K -11.6K -6.17% $30.04 177K Nov 2, 2023 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COCO Non-Qualified Stock Option (right to buy) Options Exercise $0 -11.6K -7.79% $0.00 137K Nov 2, 2023 Common Stock 11.6K $10.18 Direct F6
holding COCO Non-Qualified Stock Option (right to buy) 205K Nov 1, 2023 Common Stock 205K $10.18 Direct F7
holding COCO Non-Qualified Stock Option (right to buy) 34.1K Nov 1, 2023 Common Stock 34.1K $10.18 Direct F8
holding COCO Non-Qualified Stock Option (right to buy) 58K Nov 1, 2023 Common Stock 58K $15.00 Direct F9
holding COCO Non-Qualified Stock Option (right to buy) 43K Nov 1, 2023 Common Stock 43K $15.36 Direct F10
holding COCO Non-Qualified Stock Option (right to buy) 14.2K Nov 1, 2023 Common Stock 14.2K $16.91 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.24, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 Due to a clerical error on the Reporting Person's Form 4 filing on December 1, 2022, the number of shares beneficially owned was inadvertently understated by 11,667 shares. The amounts in Column 5 list the correct number of shares beneficially owned.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.17, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F6 The stock option is fully vested and currently exercisable.
F7 The stock option is fully vested and currently exercisable with respect to 102,375 underlying shares. The remainder will vest on February 10, 2024.
F8 The stock option vests in two equal installments on January 11, 2023 and January 11, 2025.
F9 The stock option vests in four equal annual installments beginning on November 27, 2022.
F10 The stock option vests in three equal annual installments beginning on August 15, 2025.
F11 The stock options vest in four annual equal installments beginning on March 10, 2024.